XALKORI 200MG CAPSULAS. Panama - anglais - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

xalkori 200mg capsulas.

pfizer europe ma eeig. - crizotinib - crizotinib....200.00mg

Xalkori capsules Arménie - anglais - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

xalkori capsules

pfizer manufacturing deutschland gmbh - crizotinib - capsules - 200mg

Xalkori capsules Arménie - anglais - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

xalkori capsules

pfizer manufacturing deutschland gmbh - crizotinib - capsules - 250mg

Xalkori Australie - anglais - Department of Health (Therapeutic Goods Administration)

xalkori

pfizer australia pty ltd - crizotinib -

ALUNBRIG brigatinib 90 mg film-coated tablet blister pack Australie - anglais - Department of Health (Therapeutic Goods Administration)

alunbrig brigatinib 90 mg film-coated tablet blister pack

takeda pharmaceuticals australia pty ltd - brigatinib, quantity: 90 mg - tablet, film coated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; sodium starch glycollate type a; magnesium stearate; hydrophobic colloidal silica anhydrous; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive locally advanced or metastatic non-small cell lung cancer (nsclc).

ALUNBRIG brigatinib 90 mg and 180 mg film-coated tablets blister pack Australie - anglais - Department of Health (Therapeutic Goods Administration)

alunbrig brigatinib 90 mg and 180 mg film-coated tablets blister pack

takeda pharmaceuticals australia pty ltd - brigatinib, quantity: 180 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; hydrophobic colloidal silica anhydrous; sodium starch glycollate type a; lactose monohydrate; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive locally advanced or metastatic non-small cell lung cancer (nsclc).

ALUNBRIG brigatinib 30 mg film-coated tablet blister pack Australie - anglais - Department of Health (Therapeutic Goods Administration)

alunbrig brigatinib 30 mg film-coated tablet blister pack

takeda pharmaceuticals australia pty ltd - brigatinib, quantity: 30 mg - tablet, film coated - excipient ingredients: lactose monohydrate; sodium starch glycollate type a; hydrophobic colloidal silica anhydrous; microcrystalline cellulose; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive locally advanced or metastatic non-small cell lung cancer (nsclc).

ALUNBRIG brigatinib 180 mg film-coated tablet blister pack Australie - anglais - Department of Health (Therapeutic Goods Administration)

alunbrig brigatinib 180 mg film-coated tablet blister pack

takeda pharmaceuticals australia pty ltd - brigatinib, quantity: 180 mg - tablet, film coated - excipient ingredients: hydrophobic colloidal silica anhydrous; sodium starch glycollate type a; magnesium stearate; microcrystalline cellulose; lactose monohydrate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350 - alunbrig is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)-positive locally advanced or metastatic non-small cell lung cancer (nsclc).

Xalkori Capsule 200 mg Bahreïn - anglais - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

xalkori capsule 200 mg

bahrain pharmacy - crizotinib - capsule - 200

Xalkori Capsule 250 mg Bahreïn - anglais - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

xalkori capsule 250 mg

bahrain pharmacy - crizotinib - capsule - 250